Chen Z W, Bergman T, Jörnvall H, Bonetto V, Norberg A, Mutt V, Longone P, Costa E, Efendic S, Ostenson C G
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Regul Pept. 1997 Mar 26;69(2):63-8. doi: 10.1016/s0167-0115(97)02126-5.
Two forms of diazepam-binding inhibitor (DBI) have been purified from chicken intestine and identified as the intact avian polypeptide (residues 1-86) and a truncated variant (residues 35-86). At 10 nM concentration, both the intact and the truncated peptide suppress in vitro-monitored glucose-induced insulin release by 50 (p < 0.02) and 64% (p < 0.01) respectively. The truncation starts at a segment. -Thr-Val-Gly-Asp-, that is strictly conserved between characterized DBI species, indicating special restrictions on the structure. However, overall DBI conservation appears to be complex. A number of differently bioactive fragments with separate processings and tissue distributions have been observed, suggesting multiple functions of DBI and its sub-segments.